University of Florida Obsessive Compulsive Disorder Program

Mt. Washington Pediatric Hospital's President & CEO Announces Plans to Retire

Retrieved on: 
Tuesday, May 24, 2022

BALTIMORE, May 24, 2022 /PRNewswire-PRWeb/ -- Mt. Washington Pediatric Hospital (MWPH), a leader in pediatric care for 100 years, announced that Sheldon "Shelly" Stein, President and CEO, is retiring with plans to remain in his role through November 2022 to support this transition.

Key Points: 
  • Washington Pediatric Hospital (MWPH), a leader in pediatric care for 100 years, announced that Sheldon "Shelly" Stein, President and CEO, is retiring with plans to remain in his role through November 2022 to support this transition.
  • For two decades, Stein's leadership has been instrumental in elevating MWPH as a leader in post-acute pediatric care.
  • Washington through numerous challenges and milestones during his 20 years as CEO," said Fred Wolf III, the chair of MWPH's Board of Trustees.
  • Washington Pediatric Hospital celebrates 100 years of providing family-focused, coordinated care to all children, including those with serious, chronic, or complex medical needs.

NOCD Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Retrieved on: 
Thursday, December 9, 2021

CB Insights today named NOCD to its third annual Digital Health 150 , which showcases the 150 most promising private digital health companies in the world.

Key Points: 
  • CB Insights today named NOCD to its third annual Digital Health 150 , which showcases the 150 most promising private digital health companies in the world.
  • This years Digital Health 150 was unveiled live during CB Insights annual Future of Health event.
  • NOCD is honored to be recognized in CB Insights third annual Digital Health 150 alongside other promising digital health companies,'' said Stephen Smith CEO & CoFounder of NOCD .
  • Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies, including applicants and nominees.

Banyan Treatment Centers Introduces the Eating Disorder Program

Retrieved on: 
Monday, November 29, 2021

Banyan treats clients with substance use disorders, mental health disorders and is now launching its first Eating Disorder Program at Banyan Philadelphia .

Key Points: 
  • Banyan treats clients with substance use disorders, mental health disorders and is now launching its first Eating Disorder Program at Banyan Philadelphia .
  • Banyan's Eating Disorder Program is located in Langhorne, Pennsylvania as an outpatient program.
  • The Eating Disorder Program treats anorexia nervosa, bulimia nervosa, binge eating disorder, as well as Avoidant Restrictive Food Intake Disorder (ARFID), orthorexia, body dysmorphia, or Other Specified Feeding and Eating Disorders (OSFED).
  • If you or someone you know is struggling with an eating disorder, mental health disorder, or substance use disorder, please call us today at (888) 230-3122.

NOCD Raises $33 Million to Address Global OCD Crisis; Series B Financing to Support People Struggling with OCD, Fuel Growth

Retrieved on: 
Tuesday, September 21, 2021

NOCD, for the first time, offers an accessible and effective solution for one of the most prevalent and stigmatized behavioral health populations people with OCD.

Key Points: 
  • NOCD, for the first time, offers an accessible and effective solution for one of the most prevalent and stigmatized behavioral health populations people with OCD.
  • We look forward to working with our investors who participated in this financing to accelerate our mission to improve the lives of people with OCD and support our significant growth.
  • Inside the NOCD platform, members can receive ongoing, face-to-face telehealth sessions from licensed NOCD therapists that specifically specialize in OCD treatment.
  • Were excited to support NOCD as the platform scales to address the needs of millions suffering from OCD.

nView Health Announces Expansion of Behavioral Health Solutions Portfolio to Include World's Leading Obsessive Compulsive Disorder Measurements

Retrieved on: 
Wednesday, April 14, 2021

b'ATLANTA, April 14, 2021 /PRNewswire-PRWeb/ --nView Health, the premier provider of evidence-based behavioral health solutions, is pleased to announce the addition of a series of new products to comprehensively address a series of mental health disorders specific to Obsessive Compulsive Disorder (OCD).

Key Points: 
  • b'ATLANTA, April 14, 2021 /PRNewswire-PRWeb/ --nView Health, the premier provider of evidence-based behavioral health solutions, is pleased to announce the addition of a series of new products to comprehensively address a series of mental health disorders specific to Obsessive Compulsive Disorder (OCD).
  • nView\'s OCD measurements include:\n"The addition of these world-renowned proprietary solutions is exciting and timely given the escalating global mental health crisis," said Dr. Thomas Young, Founder and Chief Medical Officer at nView Health.
  • "This is another large step forward for nView as we grow our digital platform of the world\'s leading behavioral health assessment technologies and make these solutions widely available to our research and healthcare provider customers around the world.
  • Anyone interested in using the OCD measurements or other exclusive nView assessment tools should reach out via our website, nview.com , to learn more about nView solutions and licensing.

NOCD Announces Results of a Clinical Trial on the Efficacy of its Mobile App Integrated with Exposure and Response Prevention for Treatment of Obsessive-Compulsive Disorder

Retrieved on: 
Monday, June 8, 2020

The results from the clinical trial demonstrate significant benefits of an integrated treatment approach combining live therapy and NOCD's mobile app in reducing OCD symptoms.

Key Points: 
  • The results from the clinical trial demonstrate significant benefits of an integrated treatment approach combining live therapy and NOCD's mobile app in reducing OCD symptoms.
  • The Columbia University Medical Center data underlines the importance of our stepped-care model and shows the benefits of integrated Exposure and Response Prevention therapy with an OCD therapist and our NOCD platform."
  • The integrated treatment program (called Brief Exposure and Response Prevention Assisted by Mobile app, or BEAM) consisted of three to five live sessions with therapists followed by five weekly phone calls.
  • The treatment was supported by the NOCD mobile app to promote patient accountability and tracking of exposures and response prevention.